Neuberger Small-Mid Cap ETF NBSM
29.02 USD -0.23 (-0.79%)
Nov 12, 2026, 2:47 PM EST
29.01 Day range 29.24
24.31 52-week range 29.61
- YTD
- +14.98%
- 1 year
- +14.34%
News
benzinga.com Haemonetics Stock Hits 52-Week High - Here's Why Haemonetics stock hits a new 52-week high after CSL Plasma outlines a sweeping rollout of its technology across existing U.S. centers.
benzinga.com Toro Lowers Full-Year Outlook As Residential Sales Slump, Costs Weigh on Margins Toro Q2 sales down 2% Y/Y to $1.32B, missing consensus of $1.35B. Residential segment sales fell 11.4%, segment earnings down to $16.1M from $36.1M. Professional segment sales up 0.8%, segment…
benzinga.com ITT Q1 Preliminary Results: Flat Revenue, Eyes $1 Billion In Orders, $500 Million In New Buybacks & More ITT shares down premarket as company reports preliminary Q1 results and announces intent to repurchase up to $500 million in shares
benzinga.com Toro's Q1 Sales Miss Expectations, Weighed Down by Material Costs and Promotions Toro Co (NYSE: TTC) reported lower Q1 fiscal 2025 results, with sales down 1% Y/Y to $995M. Adjusted EPS of $0.65 beat consensus of $0.63. FY25 outlook reaffirmed.
benzinga.com 'Russian Nesting Doll' Of Problems: MSTX And DIPS Top Morningstar's Worst ETF List For 2024 Two leveraged exchange-traded funds (ETFs) have been identified as the worst performers of the year, according to Morningstar.
benzinga.com Why Is Outdoor Equipment Products Provider Toro Stock Plunging Today? Toro Co shares down after reporting Q3 results with sales increase of 6.9% but missing consensus, adjusted gross margin and operating margin up, adjusted EPS misses and lower FY24 outlook due to…
benzinga.com Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix analysis. Price target set at $112.- benzinga.com Why Is RBC Bearings Stock Trading Higher Today? RBC Bearings reported Q4 results with net sales up 4.9%, gross margin and EBITDA margin expanding. Backlog at $726.1M. Adjusted EPS beat estimates.